ORMP

Oramed Pharmaceuticals Inc. Press Releases

$6.54
*  
0.48
6.84%
Get ORMP Alerts
*Delayed - data as of Mar. 27, 2015  -  Find a broker to begin trading ORMP now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By

Oramed to Present at the ROTH Conference
3/4/2015 8:15:00 AM - PR Newswire




Oramed to Present at the BIO CEO & Investor Conference
2/5/2015 8:25:00 AM - PR Newswire


Oramed Pharmaceuticals Inc. Issues Letter to Shareholders
1/28/2015 9:00:00 AM - PR Newswire
▲32.39 % Price Change since this news event. The Volume Ratio is 12.2.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Oramed Granted Patent in Israel for Oral Administration of GLP-1
1/16/2015 8:25:00 AM - PR Newswire
▲44.69 % Price Change since this news event. The Volume Ratio is 3.1.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day